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MaOBJECTIVES The objective of this study was to test the hypothesis that the extent and severity of left ventricular
myocardial hypoperfusion at rest, in addition to signs of left ventricular myocardial scar, are related to adverse long-term
outcome in patients with non–ST-segment elevation myocardial infarction (NSTEMI).
BACKGROUND Multidetector computed tomography (MDCT) is a noninvasive test with a spatial resolution that allows
for the assessment of transmural myocardial perfusion. In patients with suspected NSTEMI, the assessment of myocardial
hypoperfusion could be clinically useful.
METHODS MDCT was performed at rest before invasive treatment in 396 patients with NSTEMI. The transmural
involvement of left ventricular hypoperfusion, the presence of intramyocardial fat or calciﬁcation, a summed defect score
adding the extent of left ventricular myocardial hypoperfusion (0 to 64 point scale), and the transmural attenuation ratio
between the subendocardial and the subepicardial myocardium were assessed. The study endpoint was a combination of
death and hospitalization due to heart failure.
RESULTS The median follow-up time of the study was 50 months, and the study endpoint was reached in 56 (15%) of
the patients. In a Cox proportional hazards survival model with adjustments for known risk factors, both the summed
defect score and transmural attenuation ratio were independently associated with adverse outcome (hazard ratio [HR]:
1.07; 95% conﬁdence interval [CI]: 1.02 to 1.11; p ¼ 0.004 and HR: 0.61; 95% CI: 0.44 to 0.85; p ¼ 0.003, respectively).
The presence of intramyocardial fat or calciﬁcation was also associated with adverse outcome (HR: 3.5; 95% CI: 1.2 to
10.7; p ¼ 0.03) when compared with patients without any perfusion defect.
CONCLUSIONS The extent and severity of left ventricular myocardial hypoperfusion at rest and signs of left
ventricular myocardial scar assessed with MDCT before invasive treatment is strongly linked to adverse long-term
outcome in patients with NSTEMI. (J Am Coll Cardiol Img 2015;8:684–94) © 2015 by the American College of
Cardiology Foundation.T he correlation between the magnitude ofmyocardial ischemia and adverse outcomehas been demonstrated in patients with
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AB BR E V I A T I O N S
AND ACRONYM S
CTA = computed tomography
angiography
LVEF = left ventricular
ejection fraction
MDCT = multidetector
computed tomography
NSTEMI = non–ST-segment
myocardial infarction
SDS = summed defect score
TAR = transmural attenuation
ratio
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685with non–ST-segment elevation myocardial infarction
(NSTEMI).
Multidetector computed tomography (MDCT) cor-
onary angiography is indicated in patients with chest
pain and intermediate likelihood of coronary artery
disease, but recently it also has been proposed as a
valuable diagnostic tool in patients with suspected
acute coronary syndrome, thus including patients
with NSTEMI (2,3). Interestingly, assessment of
regional myocardial perfusion (including areas of
hypoperfusion) in patients with myocardial infarction
may be performed with use of coronary computed
tomography angiography (CTA) (4–8). MDCT has the
advantage of submillimeter spatial resolution, which
permits the assessment of transmural myocardial
perfusion gradients in addition to signs of myocardial
scar such as the presence of myocardial calciﬁcation
or myocardial lipomatous metaplasia (9,10). Myocar-
dial calciﬁcation and lipomatous metaplasia are
regarded as signs of myocardial scar formation (11).SEE PAGE 695We tested the hypothesis that the extent and
severity of left ventricular myocardial hypoperfusion
at rest in addition to signs of myocardial scar as
assessed by MDCT are related to adverse long-term
outcome in patients with NSTEMI.
METHODS
Consecutive patients with NSTEMI referred to Rig-
shospitalet, Copenhagen, Denmark, were scanned
with cardiac MDCT prior to invasive investigation as
part of a research protocol. Included patients were
classiﬁed into 3 groups according to regional myocar-
dial perfusion ﬁndings at rest by qualitative MDCT
analysis: 1) patients with normal myocardial perfu-
sion; 2) patients with myocardial hypoperfusion who
did not have a scar; and 3) patients with myocardial
hypoperfusion who had a scar. In patients with
myocardial hypoperfusion, the regional transmural
extent of hypoperfusion was graded as mild, moder-
ate, or severe. Semiquantitative parameters of myo-
cardial perfusion were related to long-term outcome.
All patients underwent medical and invasive treat-
ment according to contemporary clinical practice. The
clinical outcome of all patients was recorded for a
minimum of 2 years. The primary endpoint was a
composite of death from any cause and hospitalization
for heart failure. Information on mortality was ob-
tained from validated databases in Denmark (Green
System, CSC Scandihealth, Aarhus, Denmark) and the
Faroe Islands (COSMIC registry, Cambio Healthcare
Systems, Aarhus, Denmark). Information regardinghospitalization due to heart failure was ob-
tained from a systematic review of all hospital
admissions after the index myocardial infarc-
tion and was deﬁned as admission because of
dyspnea, with objective signs of pulmonary
congestion and treatment with intravenous
diuretics. Veriﬁcation of hospitalization due
to heart failure was performed by an inde-
pendent reviewer blinded to clinical data.
NSTEMI was deﬁned according to European
guidelines as symptoms with acute chest pain
and/or electrocardiography changes without
persistent ST-segment elevation and a char-
acteristic rise and fall in plasma troponin T (12).
Patients with a contraindication to coronary CTA,
including a history of chronic renal disease or serum
creatinine >125 mmol/l, cardiac arrhythmia, and
known allergy to iodine contrast medium, along with
patients with hemodynamic instability and those who
declined to participate, were not enrolled in the
study. The protocol was approved by the Committees
on Biomedical Research for the Capital Region
of Denmark (protocol #KF01318727), and written
informed consent was obtained from all patients.
Invasive coronary angiography was performed
within 2 weeks of diagnosis according to Danish prac-
tice during the period of study inclusion (13). The
median time between coronary CTA and invasive cor-
onary angiography was 4 h (interquartile range: 2 to
18 h) with no delays due to a coronary CTA. Treatment
was determined by an interventional cardiologist
who was blinded to coronary CTA ﬁndings. The num-
ber of diseased vessels was determined on the basis of
invasive coronary angiography as >50% diameter ste-
nosis in the 3 major branches and the left main stem.
Clinical signs of heart failure within 5 days prior to
coronary CTA were recorded according to Killip class.
MDCT IMAGING. Scanning was performed with a
64-slice MDCT scanner (Toshiba Aquillion, Tochigi,
Japan) using a retrospective scanning technique. The
scanner settings were as follows: tube voltage: 120
to 135 kV; detector collimation: 64  0.5 mm; and
rotation time: 350 to 500 ms. Depending on the ex-
pected scan time, 70 to 100 ml of contrast agent (Vis-
ipaque 320, GE Healthcare, Buckinghamshire, United
Kingdom) was infused with a rate of 5 ml/s, and image
acquisition was initiated by automatic bolus trig-
gering. An automatic raw data motion analysis tool
(PhaseXact, Toshiba Medical Systems Corp., Otawara,
Japan) was used to select the optimal motion-free
mid-diastolic phase used for myocardial analysis.
Images were reconstructed with 0.5-mm slice thick-
ness. Image data were transferred to an external
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686workstation (Vitrea 6.2, Vital Images, Minnetonka,
Minnesota, myocardial perfusion application) for
further analysis blinded to clinical information and
ﬁndings of the coronary angiography.
IMAGE ANALYSIS. Myocardial perfusion image anal-
ysis was assessed using a window width and level of
300/150 Hounsﬁeld units (HU) and a slice thickness of
3.5 mm (average projection) with slight adjustments
for each individual patient. All studies were exam-
ined systematically for artifacts as a consequence of
motion, misalignment, and beam hardening as pre-
viously described (14).
QUALITATIVE EVALUATION OF MYOCARDIAL
PERFUSION. The left ventricular myocardium was
divided into 16 segments based on the standard
segment model, with the apex region excluded from
the analysis. Each myocardial segment were assigned
a visual severity score as follows: 0 ¼ normal
myocardial perfusion, deﬁned as myocardium with
a homogenous contrast distribution relative to
the remainder of the left ventricular myocardium;
1 ¼ mild hypoperfusion, deﬁned as an area with
hypoperfusion (¼ myocardial perfusion defect)
involving less than one-third of the transmural extent
of the myocardium (Figure 1A); 2 ¼ moderate hypo-
perfusion greater than one-third but less than
one-half transmural (Figure 1B); 3 ¼ severe hypo-
perfusion involving greater than one-half transmural
(Figure 1C) or hypoperfusions with myocardial thin-
ning (Figure 1D, see deﬁnition in the following text);
and 4 ¼ MDCT sign of myocardial scar (Figures 1E and
1F, see deﬁnition in the following text). Each
myocardial segment was assigned a full severity score
if >50% of the circumferential extent of the segment
as presented on the short axis view was involved and
half severity score if 25% to 50% of the myocardial
segment was involved. If <25% of the segment was
involved, the severity score was assigned a value of 0.
Patients were classiﬁed according to their worst
visual severity score into 5 groups: normal perfusion,
mild hypoperfusion, moderate hypoperfusion, severe
hypoperfusion, or MDCT signs of myocardial scar.
Myocardial hypoperfusion accompanied by the
presence of myocardial thinning was assigned 3
points in this severity score scale (3). Myocardial
thinning was deﬁned as 1 or more myocardial seg-
ments that were thinned >50% relative to the adja-
cent myocardium.
“MDCT signs of myocardial scar” was deﬁned
by the presence of myocardial calciﬁcation or myo-
cardial lipomatous metaplasia. Myocardial lipoma-
tous metaplasia was deﬁned as myocardial perfusion
defects in which a 5-mm2 region of interest in thedefect was >3 SD below the baseline attenuation of
normal myocardium on noncontrast images (25 HU).
Using noncontrast images of the ﬁrst 100 included
subjects without a history of previous myocardial
infarction, this threshold was deﬁned as the mean
attenuation density of a 10-mm2 region of interest
placed in the lateral wall, in the apex, and in the
septum on a mid-ventricular short axis plane, and the
result was in accordance with previous studies
assessing lipomatous metaplasia (9,10).
SEMIQUANTITATIVE ASSESSMENT OF MYOCARDIAL
PERFUSION. On the basis of qualitative severity
scores, a semiquantitative summed defect score (SDS)
was calculated for each patient as the sum of the
severity scores of all segments. Because the presence
of extensive perfusion defects may give the same risk
of adverse outcome compared with MDCT signs of
myocardial scar, we performed a sensitivity analysis
in which segments with MDCT signs of myocardial
scar were given a visual severity score of 3, 2, and 1 in
the SDS calculation.
Semiquantitative evaluation of the transmural
myocardial perfusion gradient between the sub-
endocardial myocardium and the subepicardial myo-
cardium was achieved by dividing the myocardium
into 3 equally sized layers with the use of semi-
automated software and subsequently calculating the
transmural attenuation ratio (TAR) as the ratio be-
tween the average attenuation of subendocardial and
subepicardial voxels as previously described (15,16).
Interobserver variability of SDS and presence of
myocardial scar was assessed for all patients by 2 in-
dependent observers. Interobserver variability of TAR
was assessed in 200 randomly selected patients. Left
ventricular end-diastolic volume indexed to body
surface area and left ventricular ejection fraction
(LVEF) were measured with use of MDCT images.
STATISTICAL ANALYSES. Continuous variables that
were normally distributed were presented as mean 
SD, and continuous data that were not normally
distributed were presented as median and inter-
quartile range. Categorical variables were presented
as frequencies and percentages.
For statistical comparisons, a 2-tailed Student t
test for independent samples was used for contin-
uous values, and the chi-square test was used for
categorical variables. Continuous variables that were
not normally distributed were compared with the
Kruskal-Wallis test.
Interobserver variability of SDS and TARwas assessed
using the Bland-Altman method, and the presence
of any perfusion defect, lipomatous metaplasia, and
calciﬁcation was assessed with Kappa statistics.
FIGURE 1 Defect Score and Transmural Attenuation Ratio Assessment With MDCT
(A) Mild subendocardial perfusion defect. (B) Moderate subendocardial perfusion defect. (C) Transmural perfusion defect. (D) Myocardial
thinning. (E) Myocardial lipomatous metaplasia. (F) Myocardial calciﬁcation. (A to E) Left panels: vertical long axis; right panels: short axis
view. (G) Patient from (C) showing a left ventricle overlay map with transmural attenuation ratio values in color code as follows: blue: >0.99,
green: 0.98 to 0.97; yellow: 0.96 to 0.94; orange: 0.93 to 0.60; and red: <0.60.
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687The relationship between outcome and the pres-
ence of myocardial perfusion defects or scar and
tertiles of SDS and TAR was plotted according to the
Kaplan-Meier method. A univariable Cox propor-
tional hazards survival analysis was performed for
potential predictors of clinical events. A multivari-
able regression analysis with forced entry of SDS
and TAR was performed separately with adjustment
for established clinical predictors including age,diabetes, previous myocardial infarction, number
of diseased vessels, left ventricular end-diastolic
volume indexed to body surface area, LVEF, and
Killip class. The overall Wald chi-square of a model
with the aforementioned established variables was
compared with the same models in which either SDS
or TAR was added to assess the incremental infor-
mation of the semiquantitative assessment of the
myocardium.
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688Patients were grouped according to their worst
defect score—mild, moderate, severe, or myocardial
scar—and tested with use of the Cox proportional
hazards survival model (patients with no perfusion
defect were used as reference). The effect was tested
in a univariable model and a model including the
aforementioned known predictors of outcome.
The proportional hazard assumption was checked
through the method of cumulative residuals. The
presence of myocardial scar, SDS, and TAR was tested
for interaction with age. Statistical analysis was per-
formed using SAS version 9.13 (SAS Institute, Cary,
North Carolina).
RESULTS
Of 1,409 patients screened for participation between
December 1, 2006 and January 31, 2009, 396 patients
underwent scanning in the study (Figure 2). A total of
699 patients could not enter the study because of
logistical problems, mainly because patients were
moved from the referring hospital to Rigshospitalet
the evening before the invasive procedure and were
scheduled for invasive angiography early the nextFIGURE 2 Flow Chart of Patient Exclusion
Patient inclusion and reasons for exclusion. CT ¼ computed tomographymorning before MDCT could be performed. The image
quality in 20 patients did not permit interpretation of
myocardial perfusion, leaving a study population of
376. The mean heart rate during MDCT in the
excluded patients was 75  16 beats/min compared
with 60  13 beats/min in the remaining group
(p < 0.001). Patient demographics and treatment are
presented in Table 1.
QUALITATIVE AND SEMIQUANTITATIVE MYOCARDIAL
PERFUSION. Using qualitative assessment, we found
144 patients (38%) with normal myocardial perfusion.
Among patients with no myocardial perfusion defect,
91 (63%) required revascularization according to the
invasive angiography. In patients who had at least 1
area with hypoperfusion, the worst segment was
categorized as mild in 47 patients (13%), moderate in
98 (26%), and severe in 46 (12%), and 41 (11%) had a
myocardial scar. All patients with MDCT signs of
myocardial scar also had at least 1 perfusion defect. In
patients with myocardial thinning (n ¼ 12), the thin-
nest part of the myocardium was 3.8  0.7 mm, or
38  7% of the thickness of the surrounding
myocardium.; s-creatinine ¼ serum creatinine.
TABLE 1 Clinical Characteristics (N ¼ 376)
Age, yrs 61  12
Female 92 (24)
Body mass index, kg/m2 28  5
Comorbidities/history
Hypertension 183 (49)
Diabetes mellitus 56 (15)
Smoker (current or former) 276 (73)
Family history of ischemic heart disease 206 (53)
Previous myocardial infarction 89 (24)
Coronary artery disease
No signiﬁcant stenosis 66 (18)
1-vessel disease 135 (36)
2-vessels disease 96 (25)
3-vessels disease 79 (21)
Left main disease 19 (5)
Estimated glomerular ﬁltration rate, ml/min/1.73 m2 86  19
Left ventricular ejection fraction, % 58  13
Left ventricular end-diastolic volume, ml/m2 78  22
Plasma troponin T maximum, ng/ml 0.87  1.4
Killip class $2 42 (11)
Treatment
Medical treatment 100 (27)
Percutaneous coronary intervention 220 (58)
Coronary artery bypass graft surgery 56 (15)
Medication at discharge
Beta-blocker 314 (84)
Angiotensin-converting enzyme inhibitor 104 (28)
Angiotensin II receptor antagonist 33 (9)
Aspirin 359 (95)
Clopidogrel 353 (94)
Statin 362 (96)
Values are mean  SD or n (%).
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 6 , 2 0 1 5 Kühl et al.
J U N E 2 0 1 5 : 6 8 4 – 9 4 CT Myocardial Perfusion and Outcome in NSTEMI
689Myocardial calciﬁcation was found in 5 patients
(1%), and myocardial lipomatous metaplasia was
found in 40 (11%). Mean attenuation density in
the myocardium with lipomatous metaplasia was
–15  31 HU.
The median SDS of all patients was 4 (range 0 to
33). TAR measurements could be performed for all
patients except for 6 as a result of pacemaker artifacts
(n ¼ 2), parts of the left ventricle outside the scan
ﬁeld (n ¼ 3), or software segmentation failure (n ¼ 1).
The mean TAR (N ¼ 370) was 1.1  0.5.
INTEROBSERVER VARIABILITY. The interobserver
variability for detecting the presence of any perfusion
defect was k ¼ 0.76, and the interobserver variability
for detecting myocardial scar was k ¼ 0.93. A bias of
0.4 SDS points existed between the observers, with
95% conﬁdence intervals (CIs) of –4 to 5. No bias
existed in TAR measurements, with a 95% CI of 0.05
to –0.05.CLINICAL OUTCOME AND RELATION TO MDCT FINDINGS.
The median follow-up time was 50 months (range 27
to 65 months). During follow-up, 56 of the patients
(15%) reached 1 of the combined endpoints: 44 (12%)
died as their ﬁrst event, and 12 (3%) were admitted to
the hospital because of heart failure. Using a uni-
variable Cox regression analysis, we found that
patients reaching the primary endpoint were charac-
terized by having higher age, higher prevalence of
previous myocardial infarction and diabetes, higher
prevalence of 3-vessel or left main disease, lower
LVEF, and higher Killip class (Table 2). Clinical
outcome according to the presence of myocardial
hypoperfusion or myocardial scar and according to
tertiles of the semiquantitative perfusion variables is
provided in Figure 3.
In a multivariable Cox regression model with
adjustment for known predictors of adverse outcome,
both SDS and TAR remained signiﬁcantly associated
with outcome (Table 3). Changing the visual severity
score for segments with MDCT signs of myocardial
infarcts to 3, 2, or 1 did not change the results
signiﬁcantly. Upon using the same model in the
subgroups of patients with no history of previous
myocardial infarction and patients without myocar-
dial scar by MDCT, both SDS and TAR remained
independently correlated to adverse outcome.
Models containing SDS or TAR had signiﬁcantly
higher Wald chi-square values than did models
including previously known predictors of outcome
alone (Figure 4). A model containing SDS and risk
factors had signiﬁcantly higher Wald chi-square value
than did models including risk factors and the pres-
ence of myocardial scar (70.3 vs. 64.9; p < 0.01).
The extent of the worst transmural myocardial
involvement was found by unadjusted evaluation to
correlate with an increasing risk of events (Figure 5,
top panel). In a model adjusting for known predictors
of adverse outcome, a similar relation was noted, but
only the presence of myocardial lipomatous meta-
plasia or calciﬁcation remained signiﬁcantly associ-
ated with the endpoint (Figure 5, bottom panel).
DISCUSSION
We have demonstrated that the extent and severity of
myocardial hypoperfusion in addition to signs of
myocardial scar assessed with MDCT prior to invasive
coronary evaluation and revascularization is signiﬁ-
cantly and independently related to long-term out-
come in patients with NSTEMI. Whereas previous
studies have shown an excellent agreement between
MDCT and both single-photon emission computed
tomography (5–7) and cardiac magnetic resonance
TABLE 2 Baseline Clinical Characteristics, MDCT Findings, and Unadjusted Relation to Outcome
No Events
(n ¼ 320)
Events
(n ¼ 56)
Wald Chi-Square
Value
Hazard
Ratio
95% Conﬁdence
Interval p Value
Age, yrs 60  12 69  9 27 1.07 1.04–1.09 <0.001
Female 76 (24) 16 (29) <1 0.82 0.46–1.47 0.50
Hypertension 158 (49) 25 (45) <1 0.88 0.53–1.50 0.64
Diabetes 42 (13) 14 (25) 5 1.98 1.08–3.63 0.03
Previous myocardial infarction 69 (22) 20 (36) 5 1.86 1.08–3.22 0.03
Three-vessel and/or left main stem disease 63 (20) 26 (46) 18 3.13 1.85–5.29 <0.001
Estimated glomerular ﬁltration rate, ml/min/1.73 m2 86  19 86  19 <1 1.0 0.99–1.01 0.90
Left ventricular ejection fraction, % 59  12 50  16 27 0.96 0.94–0.97 <0.001
Left ventricular end-diastolic volume, ml/m2 77  19 83  33 3 1.01 0.99–1-02 <0.06
Troponin T maximum, ng/ml 0.84  1.3 0.99  1.8 <1 1.08 0.91–1.28 0.40
Killip class $ 2 24 (8) 18 (32) 25 4.17 2.38–7.32 <0.001
MDCT semiquantitative scores
Summed defect score 3 [0-7] 11 [4-17] 39 1.09 1.06–1.12 <0.001
Transmural attenuation ratio* 1.11  0.05 1.07  0.06 29 0.46 0.35–0.61 <0.001
Values are mean  SD, n (%), or median [interquartile range]. *The effect of transmural attenuation ratio is assessed according to SD of the variable.
MDCT ¼ multidetector computed tomography.
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690(4,8) for determining the presence and size of
myocardial perfusion defects in various patient
groups, the current study is the ﬁrst to show that
these MDCT ﬁndings translate into adverse clinical
outcomes.
Our data also demonstrate a signiﬁcant effect on
outcome after adjustment for LVEF, which suggests
that the relation between CT-derived myocardial
perfusion and global left ventricular contractile func-
tion is more complex than a simple linear correlation.
To test the proposed method, we used a high-risk
group of patients with conﬁrmed NSTEMI. Currently
the indication for coronary CTA is reserved for pa-
tients with chest pain at lower pre-test likelihood.
The clinical value of the proposed method is found in
studies that point toward an expansion of the use of
coronary CTA to include patients suspected of having
acute coronary syndrome in the emergency depart-
ment even before the results of troponin tests are
available. Some of these patients will have NSTEMI
(2,3). Further studies should explore whether coro-
nary CTA-assessed myocardial ﬁndings translate into
an adverse outcome in patients with lower probability
chest pain syndromes. The present study does not
propose and/or recommend coronary CTA in an
NSTEMI population but explores one of the poten-
tially diagnostic beneﬁts that could be achieved by
using such a strategy.
We found that the absence of perfusion abnor-
malities and MDCT signs of myocardial scar cor-
related with a low risk of an adverse outcome.
Conversely, compared with patients with normal
myocardial perfusion, we found that patients
with moderate and severe hypoperfusion had anunadjusted increase in hazard ratio of 2.4 and 5.2,
respectively. However, only the sum of the total
hypoperfusion defect load assessed in SDS was asso-
ciated with outcome independently of previously
known risk factors. This result was also found when
excluding patients with previous myocardial infarc-
tion and myocardial fat and calciﬁcation; this ﬁnding
suggests that the extent of ischemia in patients with
NSTEMI has important prognostic value.
When patients with no perfusion defects are used
as reference group, the presence of myocardial scar
remained independently signiﬁcant when adjusting
for known risk factors. In 40 of 41 patients with a
myocardial scar, the presence of lipomatous meta-
plasia was found. The histopathologic evolution of a
myocardial infarction has been described thoroughly,
including myocyte death and subsequent pressure
load increase, triggering a cascade of reparative
changes that include myocardial thinning, left ven-
tricular dilation, hypertrophy, and the formation of
collagen scar (17). Interestingly, the presence of adi-
pose tissue was not described in the classical litera-
ture on left ventricular remodeling after myocardial
infarction until 1997, when Baroldi et al. (11) pub-
lished the ﬁnding of lipomatous metaplasia in 26 of 38
explanted hearts from patients with chronic ischemic
heart disease.
Lipomatous metaplasia appears in myocardial scars
more than 10 months after infarction (10). Its presence
could be speculated to be linked to the pathogenesis
of post-myocardial infarction arrhythmias. However,
the link between the presence of MDCT sign of scar
and adverse outcome could also well be explained
by a larger extent of dysfunctional left ventricular
FIGURE 3 Survival According to Left Ventricular Myocardial Hypoperfusion and MDCT Sign of Scar
Kaplan-Meier plots of the combined study endpoint stratiﬁed into 3 qualitative visual groups (top panel). The semiquantitative scores were stratiﬁed in tertiles of
summed defect score (lower left panel) and transmural attenuation ratio (lower right panel). MDCT ¼ multidetector computed tomography.
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691myocardium in patients with a previous scar rather
than properties (e.g., arrhythmogenesis) of the scar.
Our data suggest that in the calculation of SDS, seg-
ments with MDCT sign of myocardial scar could count
the same as having a perfusion defect in terms ofTABLE 3 Adjusted Correlations Between Myocardial Perfusion
Abnormalities and Death or Hospital Admittance With
Heart Failure
Adjusted
Hazard Ratio*
95% Conﬁdence
Interval p Value
Summed defect score 1.07 1.02–1.11 0.004
Transmural attenuation ratio† 0.61 0.44–0.85 0.003
*Adjustments were made for age, previous myocardial infarction, diabetes, left
ventricular ejection fraction, left ventricular end-diastolic volume index, Killip
class, and number of diseased coronary vessels. †The effect of transmural atten-
uation ratio is assessed according to SDs of the variable.calculating risk. The clinical relevance of adipose tis-
sue should be the focus of further studies. The fact
that myocardial calciﬁcation was found in only 5 pa-
tients indicates its limited relevance for assessment
in patients with NSTEMI.
Under resting conditions, myocardial perfusion is
higher in the subendocardium than in the sub-
epicardium because the coronary tree adapts to
compensate for the ﬂow-limiting effect of myocardial
compressive forces that are greatest at the endocar-
dial surface (18). The MDCT spatial resolution allows
for an evaluation of the subendocardial/subepicardial
ratio in humans, and mean values between 1.12 and
1.16 have been found in nonischemic regions during
resting conditions (15,16). The subendocardium is the
most vulnerable part of the myocardium (18,19),
and in the presence of myocardial ischemia, the
FIGURE 4 Bar Diagram
Differences in Wald chi-square value between models with and without semiquantitative
measures of myocardial perfusion. SDS ¼ summed defect score; TAR ¼ transmural
attenuation ratio.
FIGURE 5 Risk According to the Worst Perfusion Defect of the Pati
Forest plot of hazard ratios comparing patients according to their worst
that contains 4 groups of defects using no perfusion defect as the refer
ventricular end-diastolic volume, previous myocardial infarction, left ven
vessels. CI ¼ conﬁdence interval.
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692subendocardial/subepicardial ratio drops below 1 (16).
This study is the ﬁrst to evaluate the subendocardial/
subepicardial ratio in patients with myocardial
infarction, and we found that a reduced ratio (0.92 to
1.08 in the lowest tertile) overall in the left ventricle
is correlated to adverse outcome. Measurements of
TAR, however, require additional semiautomated
software, which may limit the relevance of this
technique in an emergency situation.
Of the patients with no perfusion defect, 63%
required revascularization, and thus CT myocardial
perfusion at rest was not able to rule out signiﬁcant
stenosis. However, it is not surprising that perfusion at
rest cannot predict the need for intervention, because
resting ﬂow requires a stenosis of 90% to 100% before
ﬂow limitation is hemodynamically detectable (20).
The hemodynamic signiﬁcance and the threshold for
intervention of a coronary stenosis are best evaluated
during rest-stress testing (21). This notion has driven
the recent development of stress CT myocardial
perfusion imaging (22). Further studies should focus
on the prognostic value of CT myocardial perfusion
imaging, preferably also in lower risk patient groups
for whom coronary CTA is clinically indicated.ent
perfusion defect. The top panel displays the results of a single model
ence. In the bottom panel, adjustments were made for age, left
tricular ejection fraction, Killip class, and number of diseased coronary
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: The extent and
severity of left ventricular myocardial hypoperfusion and sign of
myocardial scar can be assessed with MDCT and has prognostic
implications incremental to that of traditional risk factors in
patients with NSTEMI.
TRANSLATIONAL OUTLOOK: Although reporting signs of
hypoperfusion and myocardial scar is possible on the basis of
MDCT images, an assessment using MDCT in more patient target
groups—including patients with chest pain who have intermedi-
ate risk of coronary artery disease—will lead to a better
understanding of the clinical value of the method.
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693PATIENT SAFETY. Contrast-induced nephropathy
was found in 5% of patients, and all increased levels
of serum creatinine returned spontaneously to
normal without any clinical manifestation. There
were no reports of serious adverse reactions to
contrast media (unpublished observations). Patients
received a total of 19  4 mSv, which is comparable to
the dose range reported from contemporary MDCT
studies at the time of inclusion. Nevertheless, the
image analysis in this study was constrained to late
diastolic images that are available in prospectively
gated scans, and thus the method described here can
be performed with much lower levels of radiation.
STUDY LIMITATIONS. No additional beta-blocker was
administered prior to MDCT examination to lower
heart rate, and in 20 patients the images were non-
evaluable, predominantly because of motion arti-
facts. Further studies should focus on the importance
of lowering the heart rate.
Although only mid-diastolic images were used for
analysis, it is a further limitation of the study that it
was not performed with contemporary scanning
techniques with prospective gating and lower tube
voltage (100 kV), which may change the appearance
of contrast defects.
Myocardial thinning is described as part of early
remodeling of the left ventricle after a myocardial
infarction (17) or may occur as part of a chronic
myocardial infarction. The underlying mechanism for
myocardial thinning is difﬁcult to distinguish using
MDCT. Thepresence of calciﬁed or lipomatous contents
in a scar suggests a chronic component. In contrast, the
presence of a mere perfusion defect in a patient with
NSTEMIwill most often be a sign of acute infarction but
may in some cases may be caused by a chronic (ﬁbrotic)
scar. In these cases a clear distinction between chronic
and acute scar is not possible with MDCT.
Patients at the highest risk were not enrolled, and
thus the study describes a low-risk group without car-
diac arrhythmias or renal dysfunction suitable for MDCT
scanning. Accordingly, the present results may not be
generalized to the average NSTEMI population (23).Although we ﬁnd a strong statistical relation to the
study endpoint, the overall number of endpoints is
low, and the results should be interpreted with
appropriate caution.
CONCLUSIONS
The extent and severity of left ventricular myocar-
dial hypoperfusion and signs of myocardial scar by
MDCT assessed before invasive treatment correlates
to long-term outcome in our group of patients
with NSTEMI. An optimized risk assessment could
possibly be achieved by adding MDCT myocardial
perfusion ﬁndings to conventional risk assessment in
patients with acute coronary syndrome. Further
studies are required to conﬁrm our results, preferably
also in patient groups at lower risk and using
contemporary scanning techniques and a multicenter
setup.
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